Physical Therapy After Anti-spastic Treatment in Children With Cerebral Palsy

NCT ID: NCT00552721

Last Updated: 2009-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is the primary purpose of this pilot study to investigate if physical therapy with strength training is better at improving muscle and gait function after anti-spastic treatment with Botulinum toxin compared to physical therapy without strength training in children with cerebral palsy. The investigators hypothesize that it is.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Physical therapy with strength training.

Group Type EXPERIMENTAL

Physical therapy with strength training

Intervention Type OTHER

12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) with an emphasis on strength training.

B

Physical therapy without strength training.

Group Type ACTIVE_COMPARATOR

Physical therapy without strength training

Intervention Type OTHER

12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) without strength training.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical therapy with strength training

12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) with an emphasis on strength training.

Intervention Type OTHER

Physical therapy without strength training

12 weeks of physical therapy after Botulinum-toxin treatment (two 45-min sessions/week) without strength training.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cerebral palsy (diplegia and hemiplegia)
* indication for anti-spastic treatment with Botulinum toxin

Exclusion Criteria

* fixed contractures
Minimum Eligible Age

7 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hvidovre University Hospital

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Bandholm, MSc

Role: PRINCIPAL_INVESTIGATOR

Gait Analysis Laboratory, Department of Orthopedic Surgery, Hvidovre University Hospital

Stig Sonne-Holm, MD, DSc

Role: STUDY_CHAIR

Gait Analysis Laboratory, Department of Orthopedic Surgery, Hvidovre University Hospital

Bente R Jensen, PhD

Role: STUDY_CHAIR

Institute of Exercise and Sport Sciences, University of Copenhagen

Søren A Pedersen, MD

Role: STUDY_CHAIR

Hvidovre University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gait Analysis Laboratory, Department of Orthopedic Surgery, Hvidovre University Hospital

Hvidovre, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KF 02 323948

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.